IP Library Granted Patent US 12,503,677
Granted Patent B2
US 12,503,677 · App. 17/304,235 · Granted Dec 23, 2025

Plant fat-based scaffolds for the growth of cell-based meats and methods of making such products

Inventors: Konrad Muller-Aufferman (Berkeley, CA); Michaela Walker (Berkeley, CA)
Assignee: Upside Foods, Inc.
C12M21/08A23L13/00A23L33/12A23L33/15A23L33/16A23L33/17C12M25/14C12M37/06C12M47/02C12N5/0658A23V2002/00C12N2533/90C12N2539/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,503,677
App. No.
17/304,235
Granted
Dec 23, 2025
Kind
B2
Abstract

A plant fat-based scaffold for growing cell-based meat products for consumption. The scaffold comprises primarily plant fats or waxes in addition to cell binding proteins and optional additional components that assist in the growth of cultivated animal cells. The scaffold can exist in both a liquified state during sterilization and a solid state during the formation of the scaffold, the seeding of the cultivated cells, and the cellular growth phase. The scaffold is capable of remaining in the final product for consumption or is partially or completely melted out of the final product and recycled into raw material for forming new scaffolds.

Claims (39)

1 . A plant fat-based strand scaffold comprising:

a. at least one plant-based saturated fatty acid or wax; and

b. a cell binding protein that enables adherence of non-human animal cells to the plant fat-based strand scaffold for growth;

wherein the at least one plant-based saturated fatty acid or wax is heated to a liquid state at a sterilization temperature; and

wherein the plant fat-based strand scaffold forms by injecting the at least one plant-based saturated fatty acid or wax in the liquid state into a bioreactor at an incorporation temperature that is cooler than the sterilization temperature.

2 . The plant fat-based strand scaffold in claim 1 , wherein the plant fat-based strand scaffold is edible.

3 . The plant fat-based strand scaffold of claim 1 , further comprising one or more secondary components chosen from nutrients and minerals to promote cellular growth, preservatives, coloring agents, flavor increasers, cell binding assistance molecules, and structural support components.

4 . The plant fat-based strand scaffold of claim 1 , wherein the non-human animal cells comprise at least one of myoblasts, myocytes, skeletal muscle progenitor cells, side population cells, mesoangioblasts, mesenchymal stem cells, fibroblasts, pericytes, adipocytes, or pluripotent stem cells.

5 . A method for forming a plant fat-based strand scaffold, said method comprising:

a. providing at least one plant-based saturated fatty acid or wax to form the plant fat-based strand scaffold;

b. heating the at least one plant-based saturated fatty acid or wax to a liquid state at a sterilization temperature;

c. injecting the at least one plant-based saturated fatty acid or wax in the liquid state into a bioreactor at an incorporation temperature that is lower than the sterilization temperature to form a solid plant fat-based strand scaffold;

d. seeding the solid plant fat-based strand scaffold with a population of non-human animal cells for growth; and

e. harvesting at least a portion of the solid plant fat-based strand scaffold and the cells of the population of non-human animal cells after cell growth is complete or after non-human animal tissue is formed.

6 . The method of claim 5 , wherein the portion of the solid plant fat-based strand scaffold can be harvested by melting the solid plant fat-based strand scaffold back into the liquid state and removing the liquid plant fat-based strand scaffold from the population of non-human animal cells.

7 . The method of claim 6 , wherein after harvesting at least the portion of the solid plant fat-based strand scaffold from the population of non-human animal cells, the liquid plant fat-based strand scaffold is recycled as raw material for a formation of another plant fat-based strand scaffold.

8 . The method of claim 5 , wherein the population of non-human animal cells comprise at least one of myoblasts, myocytes, skeletal muscle progenitor cells, side population cells, mesoangioblasts, mesenchymal stem cells, fibroblasts, pericytes, adipocytes, or pluripotent stem cells.

9 . A method for growing a non-human animal tissue product using a plant fat-based strand scaffold, said method comprising:

a. heating at least one plant-based saturated fatty acid or wax to a liquid state at a sterilization temperature;

b. forming the plant fat-based strand scaffold by injecting the at least one plant-based saturated fatty acid or wax in the liquid state into a bioreactor at an incorporation temperature that is cooler than the sterilization temperature;

c. seeding the plant fat-based strand scaffold with a population of non-human animal cells;

d. supplying the population of non-human animal cells with one or more growth nutrients;

e. growing the population of non-human animal cells; and

f. harvesting at least a portion of the plant fat-based strand scaffold and cells of the population of non-human animal cells after cell growth.

10 . The method of claim 9 , wherein the population of non-human animal cells may be supplied with one or more growth nutrients to expedite growth.

11 . The method of claim 10 , wherein the one or more growth nutrients is incorporated into the plant fat-based strand scaffold.

12 . The method of claim 11 , wherein the plant fat-based strand scaffold comprising the one or more growth nutrients has a melting temperature below an upper limit of a growth temperature range of the seeded population of non-human animal cells and below an upper end of an endurance range of the seeded population of non-human animal cells, and by raising a temperature to the melting temperature during a growth phase, the plant fat-based strand scaffold at least partially melts and releases the one or more growth nutrients.

13 . The method of claim 9 , wherein the population of non-human animal cells comprise at least one of myoblasts, myocytes, skeletal muscle progenitor cells, side population cells, mesoangioblasts, mesenchymal stem cells, fibroblasts, pericytes, adipocytes, or pluripotent stem cells.

14 . The method of claim 12 , wherein the endurance range of the population of non-human animal cells comprises between 10 degrees Celsius and 55 degrees Celsius.

15 . A method for growing non-human animal tissue product with a plant fat-based strand scaffold, said method comprising:

a. introducing a plant fat-based strand scaffolding comprising at least one plant-based saturated fatty acid or wax;

b. heating the at least one plant-based saturated fatty acid or wax to a liquid state at a sterilization temperature;

c. seeding the plant fat-based strand scaffold with a population of non-human animal cells while the plant fat-based strand scaffold is in a partially solid and partially liquid state; and

d. cooling the plant fat-based strand scaffold into a solid plant fat-based strand scaffold after the population of non-human animal cells are seeded by injecting the plant fat-based strand scaffold in the partially solid and partially liquid state into a bioreactor at an incorporation temperature that is cooler than the sterilization temperature.

16 . The method of claim 15 , wherein the plant fat-based strand scaffold comprises two or more different types of fats or waxes, each having different melting temperatures.

17 . The method of claim 16 , wherein the plant fat-based strand scaffold is seeded while at least one fat or wax is in the liquid state and at least one fat or wax is in a solid state.

18 . The method of claim 15 , wherein the incorporation temperature matches a growing temperature of the population of non-human animal cells.

19 . The method of claim 15 , further comprising: introducing one or more cell binding proteins while the plant fat-based strand scaffold is partially solid and partially liquid.

20 . The method of claim 15 , wherein the population of non-human animal cells comprise at least one of myoblasts, myocytes, skeletal muscle progenitor cells, side population cells, mesoangioblasts, mesenchymal stem cells, fibroblasts, pericytes, adipocytes, or pluripotent stem cells.

Assignments (2)
CHANGE OF NAME Recorded May 27, 2026
From: UPSIDE FOODS, INC.
To: THE UPSIDE GROUP INC.
Reel/Frame 075648/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2021
From: MULLER-AUFFERMAN, KONRAD; WALKER, MICHAELA
To: UPSIDE FOODS, INC.
Reel/Frame 056568/0715 →
Continuity (1)
Related Publication 20220403309A1 · Dec 22, 2022
References Cited (51)
US 9752122B2 · Marga et al. · 2017 [cited by applicant]
US 9974886B2 · Wang et al. · 2018 [cited by applicant]
US 20100196432A1 · Feinberg et al. · 2010 [cited by applicant]
US 20110270400A1 · Kita et al. · 2011 [cited by applicant]
US 20130029008A1 · Forgacs et al. · 2013 [cited by applicant]
US 20150079238A1 · Marga et al. · 2015 [cited by applicant]
US 20150157038A1 · Ergun · 2015 [cited by applicant]
US 20150202586A1 · Imoto et al. · 2015 [cited by applicant]
US 20160145311A1 · Shoseyov et al. · 2016 [cited by applicant]
US 20170105438A1 · Ajami et al. · 2017 [cited by applicant]
US 20190343889A1 · Luukko et al. · 2019 [cited by applicant]
US 20200157506A1 · Bayer et al. · 2020 [cited by applicant]
US 20210046220A1 · Alsberg et al. · 2021 [cited by applicant]
US 20210139843A1 · Nahmias · 2021 [cited by applicant]
US 20220125072A1 · Ben-Shitrit et al. · 2022 [cited by applicant]
US 20220403310A1 · Muller-Aufferman et al. · 2022 [cited by applicant]
JP 2020523015A · 2020 [cited by applicant]
WO WO2017035332A1 · 2017 [cited by applicant]
WO WO2018189738A1 · 2018 [cited by applicant]
WO WO2018227016A1 · 2018 [cited by applicant]
WO WO2020030628A1 · 2020 [cited by applicant]
WO 2020086941A1 · 2020 [cited by applicant]
WO 2020106743A1 · 2020 [cited by applicant]
WO WO2020123876A1 · 2020 [cited by applicant]
WO WO2020170196A1 · 2020 [cited by applicant]
WO WO2020219755A1 · 2020 [cited by applicant]
WO WO2020222239A1 · 2020 [cited by applicant]
WO WO2020227835A1 · 2020 [cited by applicant]
WO WO2020249734A1 · 2020 [cited by applicant]
Rutledge et al. “Formation of fibers by electrospinning.” Adv Drug Deliv Rev. Dec. 10, 2007;59(14):1384-91. (Year: 2007). [cited by examiner]
International Search Report & Written Opinion as received in PCT/US2021/037688 dated May 20, 2022. [cited by applicant]
Limbardo et al. “The effect of coconut oil and palm oil as substituted oils to cocoa butter on chocolate bar texture and melting point.” AI P Conference Proceedings 1840, 060001 (2017) (Year: 2017). [cited by applicant]
U.S. Appl. No. 17/572,297, Apr. 26, 2022, Office Action. [cited by applicant]
Examination Report as received in CA application 3,221,762 dated Dec. 20, 2023. [cited by applicant]
Examination Report as received in AU application 2021450828 dated Jan. 10, 2024. [cited by applicant]
Edelman et al. “Commentary: In vitro-cultured meat production” Tissue Eng .May-Jun. 2005,11(5-6):659-62. (Year: 2005). [cited by applicant]
Chriki et al. “The Myth of Cultured Meat: A Review”Front Nutr. 2020; 7: 7. (Year: 2020). [cited by applicant]
Fish et al. “Prospects and challenges for cell-cultured fat as a novel food ingredient.” Trends Food Sci Technol .Apr. 2020,98:53-67. (Year: 2020). [cited by applicant]
Guan et al. “Bioprocessing technology of muscle stem cells: implications for cultured meat.” Trends Biotechnol .Jun. 2022,40(6):721-734. (Year: 2022). [cited by applicant]
U.S. Appl. No. 17/572,297, Jan. 27, 2023, Office ACtion. [cited by applicant]
Jaganathan et al., Manufacturing and Characterization of Novel Electrospun Composite Comprising Polyurethane and Mustard Oil Scaffold with Enhanced Blood Compatibility, Polymers, May 4, 2017, vol. 9, MDPI, Basel, Switze… [cited by applicant]
De Carvalho et al., Biocompatibility of Mesenchymal Stem Cells in Wharton's Jelly of Caprine In Porous Matrix of Buriti Oil ( [cited by applicant]
Lukyanova et al., Preparation and Evaluation of Microporous Organogel Scaffolds for Cell Viability and Proliferation, Colloids and Surfaces B: Biointerfaces, Apr. 8, 2010, vol. 79, Elsevier, Amsterdam, Netherlands, pp. … [cited by applicant]
Wu et al. “Effects of storage culture media, temperature and duration on human adipose-derived stem cell viability for clinical use.” Mol Med Rep .Mar. 2019;19(3):2189-2201. (Year: 2019). [cited by applicant]
U.S. Appl. No. 17/572,297, Aug. 26, 2022, Office ACtion. [cited by applicant]
Examination Report as received in CA application 3,221,762 dated May 1, 2024. [cited by applicant]
First Office Action as received in JP application 2023-574847 dated May 27, 2024. [cited by applicant]
Notice of Acceptance as received in AU application 2021450828 dated Sep. 5, 2024. [cited by applicant]
Written Opinion as received in SG application 11202309396S dated Sep. 9, 2024. [cited by applicant]
Office Action as received in IL application 308773 dated Nov. 14, 2024. [cited by applicant]
Communication pursuant to Article 94(3) EPC as received in European Application No. 21746845.3 dated May 27, 2025. [cited by applicant]